During the past decade, GPR Klinikum Rüsselsheim conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "GPR Klinikum Rüsselsheim" #1 collaborator was "Abbott Medical Devices" with 1 trials as a collaborator and "European Cardiovascular Research Center" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "GPR Klinikum Rüsselsheim" are "Coronary Artery Stenosis" (2 trials). Many other conditions were trialed in "GPR Klinikum Rüsselsheim" in a lesser frequency.

Most popular intervention types in "GPR Klinikum Rüsselsheim" are "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "ABSORB Scaffold" (1 trials) and "PTCA - Desolve Scaffold" (1 trials). Other intervention names were less common.

The vast majority of trials in "GPR Klinikum Rüsselsheim" are 2 trials for "All" genders.

Currently, there are NaN active trials in "GPR Klinikum Rüsselsheim". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in GPR Klinikum Rüsselsheim, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in GPR Klinikum Rüsselsheim, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".